Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dosing Frequency and Medication Adherence in Chronic Disease
Craig I Coleman, Brendan Limone, Diana M Sobieraj, et al.
Journal of Managed Care Pharmacy (2012) Vol. 18, Iss. 7, pp. 527-539
Open Access | Times Cited: 392

Showing 1-25 of 392 citing articles:

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors
William H. Polonsky, Robert R. Henry
Patient Preference and Adherence (2016) Vol. Volume 10, pp. 1299-1307
Open Access | Times Cited: 603
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 513
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
Patrick Vermersch, Anna Członkowska, Luigi ME Grimaldi, et al.
Multiple Sclerosis Journal (2013) Vol. 20, Iss. 6, pp. 705-716
Open Access | Times Cited: 336
Covalent inhibitors: a rational approach to drug discovery
Fandi Sutanto, Markella Konstantinidou, Alexander Dömlingꝉ
RSC Medicinal Chemistry (2020) Vol. 11, Iss. 8, pp. 876-884
Open Access | Times Cited: 298
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Cynthia W. Ko, Siddharth Singh, Joseph D. Feuerstein, et al.
Gastroenterology (2018) Vol. 156, Iss. 3, pp. 748-764
Open Access | Times Cited: 259
Medication Non-Adherence Among Elderly Patients Newly Discharged and Receiving Polypharmacy
Luca Pasina, Antonio Brucato, Chiara Falcone, et al.
Drugs & Aging (2014) Vol. 31, Iss. 4, pp. 283-289
Closed Access | Times Cited: 234
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
Marc Decramer, Antonio Anzueto, Edward Kerwin, et al.
The Lancet Respiratory Medicine (2014) Vol. 2, Iss. 6, pp. 472-486
Closed Access | Times Cited: 231
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science
Jean C. McSweeney, Anne G. Rosenfeld, Willie M. Abel, et al.
Circulation (2016) Vol. 133, Iss. 13, pp. 1302-1331
Open Access | Times Cited: 217
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Kenneth B. Gordon, Peter Foley, James G. Krueger, et al.
The Lancet (2021) Vol. 397, Iss. 10273, pp. 475-486
Closed Access | Times Cited: 206
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Tiffany Luong, Ann-Charlott Salabarria, Dwayne R. Roach
Clinical Therapeutics (2020) Vol. 42, Iss. 9, pp. 1659-1680
Open Access | Times Cited: 200
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Tsvetelina Baryakova, Brett H. Pogostin, Róbert Langer, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 5, pp. 387-409
Open Access | Times Cited: 187
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment
Éric Rondeau, Marie Scully, Gema Ariceta, et al.
Kidney International (2020) Vol. 97, Iss. 6, pp. 1287-1296
Open Access | Times Cited: 170
Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis
Alesia Sadosky, Kunal Srivastava, Anamika Arora, et al.
Patient Preference and Adherence (2013), pp. 419-419
Open Access | Times Cited: 160
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases
Eleni Vangeli, Savita Bakhshi, Anna Baker, et al.
Advances in Therapy (2015) Vol. 32, Iss. 11, pp. 983-1028
Open Access | Times Cited: 147
Factors associated with low adherence to medicine treatment for chronic diseases in Brazil
Noêmia Urruth Leão Tavares, Andréa Dâmaso Bertoldi, Sotero Serrate Mengue, et al.
Revista de Saúde Pública (2016) Vol. 50, Iss. suppl 2
Open Access | Times Cited: 141
The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: A systematic review
Rebecca L. Kinney, Stephenie C. Lemon, Sharina D. Person, et al.
Patient Education and Counseling (2015) Vol. 98, Iss. 5, pp. 545-552
Closed Access | Times Cited: 134
Rethinking Adherence: A Health Literacy–Informed Model of Medication Self-Management
Stacy Cooper Bailey, Christine U. Oramasionwu, Michael S. Wolf
Journal of Health Communication (2013) Vol. 18, Iss. sup1, pp. 20-30
Open Access | Times Cited: 134
Medication nonadherence and psychiatry
Sarah Chapman, Rob Horne
Current Opinion in Psychiatry (2013) Vol. 26, Iss. 5, pp. 446-452
Open Access | Times Cited: 132
The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population
Pei‐Yin Pan, Meei‐Shyuan Lee, Chin‐Bin Yeh
BMC Psychiatry (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 121
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis
Siddharth Singh, Joseph D. Feuerstein, David G. Binion, et al.
Gastroenterology (2018) Vol. 156, Iss. 3, pp. 769-808.e29
Open Access | Times Cited: 109
Drug adherence in hypertension
Michel Burnier
Pharmacological Research (2017) Vol. 125, pp. 142-149
Closed Access | Times Cited: 101
Meta-analyses of Theory Use in Medication Adherence Intervention Research
Vicki S. Conn, Maithe Enriquez, Todd Ruppar, et al.
American Journal of Health Behavior (2016) Vol. 40, Iss. 2, pp. 155-171
Open Access | Times Cited: 97
Identifying the barriers to antiepileptic drug adherence among adults with epilepsy
Geraldine O’ Rourke, Julie Jordan O’ Brien
Seizure (2016) Vol. 45, pp. 160-168
Open Access | Times Cited: 97
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, et al.
Molecules (2020) Vol. 25, Iss. 23, pp. 5695-5695
Open Access | Times Cited: 80
Acinetobacter Baumannii Phages: Past, Present and Future
Qihang Tu, Mingfang Pu, Yahao Li, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 673-673
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top